U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is facing backlash after firing all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) and replacing them with eight new members, several of whom have histories of vaccine skepticism. The move has raised concerns among public health experts and lawmakers, including Senator Bill Cassidy, a Republican and physician from Louisiana who chairs the Senate Health Committee.
Cassidy had previously supported Kennedy's confirmation after receiving assurances that the ACIP structure would remain intact. “If confirmed, he will maintain the CDC’s ACIP without changes,” Cassidy had said during a Senate floor speech. However, Kennedy now says he only promised to let Cassidy choose one candidate for the panel, a pledge he intends to honor.
During a Fox News interview, Kennedy denied violating any agreement. “I told Senator Cassidy I would allow him to put one of his candidates on, which we’re going to do,” he stated. Cassidy’s office later clarified the commitment was about maintaining the ACIP process, not preventing staff changes.
Kennedy defended his decision, citing alleged conflicts of interest among the previous members, though he offered no specific evidence. His reshuffle has drawn sharp criticism from the American Medical Association, which called for an investigation and a reversal of the firings. Critics argue that stacking the panel with vaccine skeptics could undermine public trust in immunization policy.
The ACIP plays a key role in advising the CDC on who should receive vaccines after FDA approval. The controversy has intensified scrutiny of Kennedy’s long-standing views on vaccines, which often contradict mainstream medical consensus. With political and public health stakes high, the debate over ACIP’s direction is far from over.


Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Italy Supreme Court Upholds Salvini Acquittal in Migrant Kidnapping Case
U.S. House Advances GOP Healthcare Bill as ACA Subsidies Near Expiration
Honduras Election Recount Delayed Amid Protests and Political Tensions
Zelenskiy Urges Allies to Use Frozen Russian Assets as EU Summit Nears
Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
U.S. Initiates $11.1 Billion Arms Sale to Taiwan Amid Rising China Tensions
Trump Set to Begin Final Interviews for Next Federal Reserve Chair
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Trump Attends Dover Ceremony Honoring U.S. Personnel Killed in Syria
Trump Administration Moves to Keep TransAlta Coal Plant Running Amid Rising AI Power Demand
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



